Moneycontrol
HomeNewsBusinessEconomyCorona blues for agrochemical players, input lines may choke
Trending Topics

Corona blues for agrochemical players, input lines may choke

February 03, 2020 / 00:49 IST
Story continues below Advertisement

Ruchi Agrawal | Anubhav Sahu

Highlights
The viral outbreak is seen to impact trade and travel
Production and supply of many chemicals expected to take a hit
Product scarcity and price uptick to impact import-dependent companies
A few local chemical producers to benefit from price uptick and demand shift
Sharp volatility in stocks expected if situation aggravates

Story continues below Advertisement

-------------------------------------------------

The outbreak of the deadly Coronavirus poses a risk to not just human beings, but also business houses and economies. The implications are varied -- both geographically and sectorally. While many are comparing the outbreak to the SARS epidemic in 2003, the potential impact of a large-scale attack is still being assessed.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show